Total Payments
$30,721
2024 Payments
$4,218
Companies
71
Transactions
1,816
Medicare Patients
5,224
Medicare Billing
$596,648
Payment Breakdown by Category
Food & Beverage$30,163 (98.2%)
Education$557.83 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $30,163 | 1,798 | 98.2% |
| Education | $557.83 | 18 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,541 | 185 | $0 (2024) |
| Amgen Inc. | $2,465 | 134 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,379 | 124 | $0 (2024) |
| Lilly USA, LLC | $1,817 | 109 | $0 (2024) |
| Novo Nordisk Inc | $1,726 | 119 | $0 (2024) |
| PFIZER INC. | $1,666 | 95 | $0 (2024) |
| ABBVIE INC. | $1,535 | 87 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,478 | 105 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,123 | 78 | $0 (2024) |
| Astellas Pharma US Inc | $1,093 | 54 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,218 | 189 | AstraZeneca Pharmaceuticals LP ($536.97) |
| 2023 | $4,174 | 210 | AstraZeneca Pharmaceuticals LP ($397.41) |
| 2022 | $3,950 | 205 | AstraZeneca Pharmaceuticals LP ($525.28) |
| 2021 | $4,052 | 226 | AbbVie Inc. ($591.21) |
| 2020 | $3,756 | 211 | Boehringer Ingelheim Pharmaceuticals, Inc. ($454.84) |
| 2019 | $3,594 | 252 | AstraZeneca Pharmaceuticals LP ($540.70) |
| 2018 | $3,491 | 258 | Amgen Inc. ($305.21) |
| 2017 | $3,486 | 265 | AstraZeneca Pharmaceuticals LP ($430.90) |
All Payment Transactions
1,816 individual payment records from CMS Open Payments — Page 1 of 73
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.06 | General |
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.53 | General |
| Category: GI | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Oncology | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: GI | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Cardiology | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 969 | 3,713 | $409,723 | $152,363 |
| 2022 | 22 | 1,377 | 3,789 | $437,165 | $165,708 |
| 2021 | 22 | 1,355 | 2,791 | $383,040 | $143,836 |
| 2020 | 23 | 1,523 | 2,802 | $407,544 | $134,741 |
Total Patients
5,224
Total Services
13,095
Medicare Billing
$596,648
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 226 | 430 | $169,420 | $49,342 | 29.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 23 | 2,460 | $82,260 | $44,917 | 54.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $25,746 | $14,738 | 57.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 44 | 58 | $29,986 | $11,636 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 121 | $33,154 | $8,845 | 26.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 81 | 83 | $9,877 | $5,957 | 60.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 17 | 17 | $16,813 | $2,524 | 15.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 84 | $6,048 | $2,430 | 40.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 133 | 133 | $4,256 | $2,320 | 54.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 61 | $6,344 | $2,158 | 34.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,317 | $1,968 | 37.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,188 | $1,710 | 53.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 30 | 30 | $5,820 | $1,076 | 18.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 27 | 34 | $4,182 | $1,059 | 25.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 13 | 13 | $2,236 | $794.61 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 15 | $3,060 | $599.62 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 28 | $2,016 | $289.98 | 14.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 20 | 2,100 | $58,800 | $35,890 | 61.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 185 | 295 | $116,230 | $35,887 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 219 | 219 | $42,267 | $27,118 | 64.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 306 | $83,844 | $21,875 | 26.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 41 | 60 | $31,020 | $11,958 | 38.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 91 | 91 | $10,829 | $6,237 | 57.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 238 | 238 | $7,616 | $4,239 | 55.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 27 | 27 | $26,703 | $3,438 | 12.9% |
About Dr. Roger Torres, M.D
Dr. Roger Torres, M.D is a Internal Medicine healthcare provider based in New Berlin, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326091117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Torres, M.D has received a total of $30,721 in payments from pharmaceutical and medical device companies, with $4,218 received in 2024. These payments were reported across 1,816 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($30,163).
As a Medicare-enrolled provider, Torres has provided services to 5,224 Medicare beneficiaries, totaling 13,095 services with total Medicare billing of $596,648. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location New Berlin, WI
- Active Since 05/19/2006
- Last Updated 04/09/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326091117
Products in Payments
- JARDIANCE (Drug) $1,740
- ELIQUIS (Drug) $1,357
- XARELTO (Drug) $1,248
- FARXIGA (Drug) $1,169
- BREZTRI (Drug) $911.20
- VRAYLAR (Drug) $784.88
- TRELEGY ELLIPTA (Drug) $704.96
- EVENITY (Biological) $683.28
- Repatha (Biological) $682.72
- Ozempic (Drug) $672.70
- Livalo (Drug) $644.32
- ENTRESTO (Drug) $612.04
- Linzess (Drug) $557.72
- TRULICITY (Drug) $552.96
- BEVESPI AEROSPHERE (Drug) $523.11
- STIOLTO RESPIMAT (Drug) $504.48
- LINZESS (Drug) $485.42
- XIFAXAN (Drug) $455.06
- Aimovig (Biological) $453.89
- UBRELVY (Drug) $439.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Berlin
Steve Chang, Md, MD
Internal Medicine — Payments: $26,232
Internal Medicine $26,232
Malaika Mathai, M.d, M.D
Internal Medicine — Payments: $186.67
Internal Medicine $186.67
Soo Ah Kim, M.d, M.D
Internal Medicine — Payments: $136.70
Internal Medicine $136.70
Dennis Mannino, M.d, M.D
Internal Medicine — Payments: $81.66
Internal Medicine $81.66
Andrew Catanzaro, Md, MD
Internal Medicine — Payments: $70.68
Internal Medicine $70.68
Scott Fenske, M.d, M.D
Internal Medicine — Payments: $55.06
Internal Medicine $55.06